Drug Information

Drug General Information
Drug ID
D02ZBW
Former ID
DIB005411
Drug Name
LC-150444
Synonyms
LCD15-0444; Dipeptidyl peptidase IV inhibitors (oral, type 2 diabetes), LG Life Sciences
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 3 [524679]
Company
LG Life Sciences Ltd
Canonical SMILES
N1(CCCC1C(=O)c1oc(nn1)c1ccccc1)C(=O)CNC(COC)(C)C
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info Inhibitor [550262]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 524679ClinicalTrials.gov (NCT02089126) Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes. U.S.National Institutes of Health.
Ref 550262Clinical pipeline report, company report or official report of ShangHai APIs Chemical.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.